CEREBROVASCULAR DISEASES is a prestigious journal published by KARGER that focuses on the critical field of cerebrovascular health, encompassing research and advancements in cardiology and neurology. With a strong emphasis on high-quality, peer-reviewed publications, the journal has established itself as an essential resource since its inception in 1987, contributing to the understanding and management of cerebrovascular disorders. It holds a commendable Q2 ranking across various categories, including Cardiology and Cardiovascular Medicine, which underscores its influence within the research community. The journal is especially significant for professionals and researchers interested in the intersection of neurological and cardiovascular health, facilitating knowledge sharing and innovative research. Although it does not operate under an Open Access model, the journal is well-regarded for its rigorous selection criteria and impactful findings. By continuing to publish cutting-edge research, CEREBROVASCULAR DISEASES aims to foster advancements in treatment and prevention strategies for cerebrovascular diseases, thereby contributing to improved patient outcomes worldwide.

Stroke-Vascular and Interventional Neurology, published by WILEY, is a leading open-access journal dedicated to advancing the field of neurology with a particular focus on stroke and vascular interventions. Since its inception in 2021 as an open-access journal, it has fostered a collaborative environment for researchers, clinicians, and educators to share innovative findings and clinical practices that address the complexities of cerebrovascular diseases. The journal emphasizes high-quality, peer-reviewed research articles, reviews, and case studies, providing critical insights into cutting-edge therapies and surgical techniques. With an ISSN of 2694-5746, it aims to support the global medical community in improving the diagnosis, treatment, and overall management of stroke patients. Researchers and healthcare professionals benefit from its accessible content, which is vital for fostering comprehensive understanding and evidence-based practices within the realm of interventional neurology.

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

European Neurology, published by KARGER, is a distinguished journal in the field of neurology, catering to both clinical and neuroscience specialties. Since its inception in 1897 and continuing through 2024, the journal has been a vital platform for disseminating significant research findings and insights in neurology. With an ISSN of 0014-3022 and E-ISSN of 1421-9913, it ranks in the Q3 quartile in both clinical neurology and general neurology categories, reflecting its commitment to scholarly excellence while holding the 175th rank in clinical medicine and the 93rd in neuroscience, according to Scopus metrics. European Neurology facilitates a deeper understanding of neurological disorders and treatments, appealing to a diverse readership that includes researchers, clinicians, and students alike. Despite not currently offering open access, the journal’s rigorous peer-review process ensures that only high-quality research reaches its audience, making it an essential resource for those looking to stay informed in the rapidly evolving field of neurology.

Archives of Neuroscience is a multidisciplinary journal dedicated to advancing the field of neuroscience through the publication of original research articles, review papers, and case studies. Published by BRIEFLAND, this journal aims to bridge the gap between neuroscience research and clinical applications, fostering a deeper understanding of brain function, neurological disorders, and potential therapeutic approaches. With an ISSN of 2322-3944 and an E-ISSN of 2322-5769, Archives of Neuroscience serves as an essential platform for researchers, professionals, and students alike, encouraging open access to knowledge and insights that drive innovation in the field. Although coverage was discontinued in Scopus from 2016 to 2017, the journal continues to uphold rigorous standards of academic excellence, making it a valuable resource for the neuroscience community seeking to explore and disseminate new findings. The journal is committed to providing timely access to research tools and findings that are crucial for informed decision-making in both academic and clinical settings.

ACTA NEUROLOGICA BELGICA is a leading academic journal published by Springer Heidelberg, dedicated to advancing the field of neurology and medicine. With an ISSN of 0300-9009 and E-ISSN 2240-2993, this journal has been a vital resource since its inception, contributing significantly to neurological research and clinical practice. It holds a respectable impact factor with categories spanning from Q2 in Medicine (miscellaneous) to Q3 in Neurology (clinical) as of 2023, indicating its prominence in the scientific community. The journal's extensive coverage since 1959 enhances its historical relevance, while its ongoing publication until 2024 ensures the latest developments are readily accessible. Researchers and practitioners can benefit from its rigorous peer-reviewed articles, which are crucial for staying current in this rapidly evolving discipline. As a scholarly platform, ACTA NEUROLOGICA BELGICA plays a pivotal role in disseminating knowledge and fostering innovation in neurology, making it a must-read for professionals, students, and anyone involved in the field.

Physical Medicine and Rehabilitation Clinics of North America is a leading journal published by W B Saunders Co-Elsevier Inc., focusing on the multifaceted disciplines of physical medicine, rehabilitation, and related health professions. With an impressive impact factor reflecting its significant contribution to the field, this journal ranks in the Q2 quartile for both Physical Therapy and Rehabilitation categories. The journal, available in both print (ISSN: 1047-9651) and online (E-ISSN: 1558-1381), provides critical insights, clinical updates, and comprehensive reviews that are essential for researchers, practitioners, and students alike. Covering a wide spectrum of topics from innovative rehabilitation techniques to emerging trends in sports medicine, it aims to disseminate knowledge that enhances patient care and drives advancements in rehabilitation practices. With a publication history spanning from 1995 to 2024, Physical Medicine and Rehabilitation Clinics is an essential resource for those dedicated to improving functional outcomes and the quality of life for patients worldwide.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

AMERICAN JOURNAL OF NEURORADIOLOGY, published by the American Society of Neuroradiology, is a premier peer-reviewed journal dedicated to advancing the field of neuroradiology. With an ISSN of 0195-6108 and an E-ISSN of 1936-959X, the journal serves as a vital resource for clinicians, researchers, and students in the realms of neurology and radiology. With a commendable Q1 ranking in multiple categories including Medicine (Miscellaneous), Clinical Neurology, and Radiology, Nuclear Medicine and Imaging, it remains at the forefront of scholarly communication since its inception in 1980. The journal enjoys significant visibility, ranked #47 out of 333 in radiology and #81 out of 400 in clinical neurology, highlighting its impact within these competitive fields. Although it is not open access, AMERICAN JOURNAL OF NEURORADIOLOGY is committed to publishing innovative research that enhances clinical practice and informs neurological imaging techniques, making it an essential read for anyone involved in the advanced study of neuroradiology.

Stroke and Vascular Neurology is a premier open access journal published by BMJ PUBLISHING GROUP, dedicated to advancing the field of vascular neurology and cardiology. With an ISSN of 2059-8688 and an E-ISSN of 2059-8696, the journal has established itself as a leading platform for disseminating cutting-edge research since its transition to open access in 2016. Based in the United Kingdom, at BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND, the journal's outstanding reputation is reflected in its Q1 rankings in both Cardiology and Cardiovascular Medicine and Neurology (clinical) for 2023, placing it in the top tier of its categories. With Scopus rankings of 28 out of 387 in Cardiology and 30 out of 400 in Neurology (clinical), both within the 92nd percentile, Stroke and Vascular Neurology serves as an essential resource for researchers, clinicians, and students looking to stay at the forefront of advancements in the management and understanding of stroke-related disorders. The journal's commitment to high-quality research contributes significantly to improving patient outcomes and shaping the future of vascular health.